• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于社交恐惧症评估的利博维茨社交焦虑量表、社交焦虑与痛苦量表及希恩功能障碍量表西班牙语版本的验证]

[Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia].

作者信息

Bobes J, Badía X, Luque A, García M, González M P, Dal-Ré R

机构信息

Area de Psiquiatría, Facultad de Medicina, Universidad de Oviedo, Madrid.

出版信息

Med Clin (Barc). 1999 Apr 24;112(14):530-8.

PMID:10363239
Abstract

BACKGROUND

Social phobia is an anxiety disorder of increasing interest in clinical psychiatric practice and research. The questionnaires most widely used in the psychometric evaluation of these patients are: Liebowitz Social Anxiety Scale (LSAS), Social Anxiety and Distress Scale (SADS) and Sheehan Disability Inventory (SDI). The objective of this study was to evaluate the validity and reproducibility of the Spanish versions.

SUBJECTS AND METHODS

Convergent validity was analysed by correlating patients' scores on the LSAS, SADS and SDI with scores on the Global Activity Evaluation Scale (GAES), the Hamilton Anxiety Scale (HAM-A) and the Visual Analogue Scale (VAS) of the EuroQol. Validity of the internal structure was examined by analysing the correlations between the different sub-escales of the questionnaires. Internal consistency was analysed using Cronbach's alpha and Kuder-Richardson coefficients. Discriminative capability was analysed by comparing LSAS, SADS and SDI scores of patients with social phobia with scores from healthy subjects, and with that obtained on the HAM-A and the EuroQol VAS. Reproducibility was analysed by re-testing patients after 15 days.

RESULTS

57 patients and 57 healthy subjects were recruited in 4 psychiatric centres. The three questionnaires showed an adequate convergent validity with the GAES, the HAM-A and the EuroQol VAS (r = -0.24-0.40 and r = 0.29-0.52). The LSAS and SDI questionnaires showed a homogenous internal structure in terms of correlation between sub-scales (r = -0.61-0.93 for LSAS, and r = -0.04-0.61 for SDI). All the sub-scales of the questionnaires showed an adequate internal consistency (with coefficients between 0.72 and 0.88). The questionnaires discriminated between groups of patients with different levels of symptom severity and self-perceived overall health. They also discriminated between patients with social phobia and healthy subjects (area under the Receiver's Operating Characteristics curves = 0.95-0.99). All sub-scales from the questionnaires showed adequate reproducibility (with intraclass correlation coefficients between 0.63 and 0.88).

CONCLUSIONS

The Spanish versions of the LSAS, SADS and SDI questionnaires have shown adequate validity and reproducibility for use in clinical research and the clinical assessment of patients with social phobia in Spain.

摘要

背景

社交恐惧症是一种在临床精神科实践和研究中越来越受关注的焦虑症。在对这些患者进行心理测量评估时使用最广泛的问卷有:利博维茨社交焦虑量表(LSAS)、社交焦虑与痛苦量表(SADS)和希恩残疾量表(SDI)。本研究的目的是评估西班牙语版本的有效性和可重复性。

受试者与方法

通过将患者在LSAS、SADS和SDI上的得分与全球活动评估量表(GAES)、汉密尔顿焦虑量表(HAM - A)以及欧洲生活质量视觉模拟量表(VAS)的得分进行相关性分析,来分析收敛效度。通过分析问卷不同子量表之间的相关性来检验内部结构的有效性。使用克朗巴哈α系数和库德 - 理查森系数分析内部一致性。通过比较社交恐惧症患者的LSAS、SADS和SDI得分与健康受试者的得分,以及与HAM - A和欧洲生活质量VAS上获得的得分,来分析区分能力。通过在15天后对患者进行重新测试来分析可重复性。

结果

在4个精神科中心招募了57名患者和57名健康受试者。这三份问卷与GAES、HAM - A和欧洲生活质量VAS显示出足够的收敛效度(r = -0.24 - 0.40以及r = 0.29 - 0.52)。就子量表之间的相关性而言,LSAS和SDI问卷显示出同质的内部结构(LSAS的r = -0.61 - 0.93,SDI的r = -0.04 - 0.61)。问卷的所有子量表都显示出足够的内部一致性(系数在0.72至0.88之间)。这些问卷能够区分不同症状严重程度和自我感知总体健康水平的患者组。它们还能区分社交恐惧症患者和健康受试者(受试者工作特征曲线下面积 = 0.95 - 0.99)。问卷的所有子量表都显示出足够的可重复性(组内相关系数在0.63至0.88之间)。

结论

LSAS、SADS和SDI问卷的西班牙语版本在西班牙用于社交恐惧症患者的临床研究和临床评估时,已显示出足够的有效性和可重复性。

相似文献

1
[Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia].[用于社交恐惧症评估的利博维茨社交焦虑量表、社交焦虑与痛苦量表及希恩功能障碍量表西班牙语版本的验证]
Med Clin (Barc). 1999 Apr 24;112(14):530-8.
2
Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.在一家三级医疗情绪与焦虑症服务机构就诊的门诊患者中,不同诊断下的社交焦虑症状。
J Affect Disord. 2009 Apr;114(1-3):305-9. doi: 10.1016/j.jad.2008.06.003. Epub 2008 Jul 25.
3
[Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].[创伤后应激障碍的评估:一种测量工具——创伤后应激障碍检查表(PCLS)的效度验证]
Encephale. 2003 May-Jun;29(3 Pt 1):232-8.
4
Functional impairment in social phobia.社交恐惧症中的功能损害。
J Clin Psychiatry. 1994 Aug;55(8):322-31.
5
Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.社交焦虑与对负面评价的恐惧:BFNE-II的结构效度
J Anxiety Disord. 2007;21(1):131-41. doi: 10.1016/j.janxdis.2006.03.010. Epub 2006 May 3.
6
[Evidence-based medicine and the validation of quality-of-life questionnaires: the Spanish version of the MOS-HIV questionnaire for the evaluation of the quality of life in patients infected by HIV].[循证医学与生活质量问卷的验证:用于评估HIV感染患者生活质量的MOS-HIV问卷西班牙语版]
Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:103-13.
7
The Liebowitz social anxiety scale for children and adolescents: an initial psychometric investigation.儿童和青少年的利博维茨社交焦虑量表:初步心理测量学调查。
J Am Acad Child Adolesc Psychiatry. 2003 Sep;42(9):1076-84. doi: 10.1097/01.CHI.0000070249.24125.89.
8
[Validation of a scale for responsibility (Salkovskis Responsibility Scale)].[责任量表(索尔科夫斯基责任量表)的验证]
Encephale. 2001 May-Jun;27(3):229-37.
9
Screening for social phobia in medical in- and outpatients with the German version of the Social Phobia Inventory (SPIN).使用德语版社交恐惧症量表(SPIN)对内科和外科门诊患者进行社交恐惧症筛查。
J Anxiety Disord. 2008 Jun;22(5):849-59. doi: 10.1016/j.janxdis.2007.08.011. Epub 2007 Sep 4.
10
Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale.使用利博维茨社交焦虑量表自评版筛查社交焦虑障碍。
Depress Anxiety. 2009;26(1):34-8. doi: 10.1002/da.20503.

引用本文的文献

1
Concurrent Validity of Digital Measures of Psychological Dimensions Associated with Suicidality Using AuxiliApp.使用AuxiliApp对与自杀倾向相关的心理维度数字测量的同时效度
Behav Sci (Basel). 2025 Jun 26;15(7):868. doi: 10.3390/bs15070868.
2
Increased default mode network activation in depression and social anxiety during upward social comparison.在向上社会比较过程中,抑郁症和社交焦虑症患者默认模式网络激活增加。
Soc Cogn Affect Neurosci. 2025 Feb 4;20(1). doi: 10.1093/scan/nsaf012.
3
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder.
卡立普嗪用于双相精神分裂症的维持治疗:一项针对精神分裂症合并大麻使用障碍患者的6个月观察性研究。
Int Clin Psychopharmacol. 2025 May 1;40(3):167-175. doi: 10.1097/YIC.0000000000000568. Epub 2024 Sep 25.
4
Patterns of cognitive-emotional change after cognitive-behavioural treatment in emotional disorders: A 12-month longitudinal cluster analysis.情绪障碍认知行为治疗后认知情感变化模式:12 个月纵向聚类分析。
PLoS One. 2024 May 7;19(5):e0301746. doi: 10.1371/journal.pone.0301746. eCollection 2024.
5
Long-term depressive symptom trajectories and related baseline characteristics in primary care patients: Analysis of the PsicAP clinical trial.长期抑郁症状轨迹及其与初级保健患者基线特征的关系:PsicAP 临床试验分析。
Eur Psychiatry. 2024 Mar 27;67(1):e32. doi: 10.1192/j.eurpsy.2024.27.
6
Treating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use.当所有治疗方案均已用尽时,使用艾氯胺酮鼻喷雾剂治疗难治性抑郁症:来自西班牙扩大使用队列的临床经验
Clin Psychopharmacol Neurosci. 2024 Feb 29;22(1):159-168. doi: 10.9758/cpn.23.1097. Epub 2023 Sep 6.
7
Engaging in Awkward Social Interactions in a Virtual Environment Designed for Exposure-Based Psychotherapy for People with Generalized Social Anxiety Disorder: An International Multisite Study.在为广泛性社交焦虑障碍患者设计的用于暴露疗法的虚拟环境中进行尴尬社交互动:一项国际多中心研究
J Clin Med. 2023 Jul 6;12(13):4525. doi: 10.3390/jcm12134525.
8
Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.跨诊断群组认知行为疗法与群组放松疗法治疗初级保健中的情绪障碍的成本效益比较(PsicAP-Costs2):一项多中心随机对照试验方案。
PLoS One. 2023 Mar 16;18(3):e0283104. doi: 10.1371/journal.pone.0283104. eCollection 2023.
9
Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.成本效益和成本效用评估个体与团体跨诊断心理治疗在初级保健中的情绪障碍(PsicAP-Costs):一项多中心随机对照试验方案。
BMC Psychiatry. 2022 Feb 9;22(1):99. doi: 10.1186/s12888-022-03726-4.
10
Psychometrics of the Spanish Version of the Screen for Adult Anxiety Related Disorders (SCAARED).成人焦虑相关障碍筛查量表(SCAARED)西班牙语版的心理测量学
Front Psychiatry. 2021 Feb 11;12:589422. doi: 10.3389/fpsyt.2021.589422. eCollection 2021.